Novian Health Secures $11,000,000 Series A Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1af0fa04-a889-4fda-aa05-910c5259eeb4&Preview=1 -
Date
2/5/2013 -
Company Name
Novian Health -
Mailing Address
430 West Erie Street Chicago, IL 60654 -
Company Description
Novian Health, located in Chicago and Evry, France, is a privately held company with proprietary technology for the treatment of tumors using Interstitial Laser Therapy (ILT). The company has developed, tested, and patented a minimally-invasive procedure, Novilase, that uses ILT (controlled heating) for the ablation of breast tumors as an alternative to the surgically invasive, traditional “lumpectomy.” -
Website
http://www.novianhealth.com -
Transaction Type
Venture Equity -
Transaction Amount
$11,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds from the funding will primarily be used to conduct Novian’s multicenter clinical trials in the U.S., Britain and France on the use of nonsurgical Novilase Interstitial Laser Therapy (ILT) for treating breast cancer. -
M&A Terms
-
Venture Investor
iNetworks -
Venture Investor
Undisclosed
